Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SHE:301234)
China · Delayed Price · Currency is CNY 99.60
-2.91 (-2.84%)
At close: Sep 11, 2026
SHE:301234 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 6,773 | 2,890 | 1,710 | 2,304 | 1,992 | - | |
Market Cap Growth | 118.18% | 68.99% | -25.77% | 15.67% | - | - |
Enterprise Value | 6,360 | 2,477 | 1,340 | 1,971 | 1,578 | - |
Last Close Price | 99.60 | 42.26 | 24.74 | 32.69 | 27.77 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 285.30 | 152.97 | 42.79 | 38.23 | 28.08 | - |
PS Ratio | 15.24 | 6.31 | 3.58 | 4.32 | 3.64 | - |
PB Ratio | 8.88 | 3.80 | 2.24 | 3.07 | 2.75 | - |
P/TBV Ratio | 8.95 | 3.83 | 2.26 | 3.10 | 2.78 | - |
P/FCF Ratio | 301.24 | 53.91 | 32.95 | 211.06 | - | - |
P/OCF Ratio | 130.62 | 39.38 | 19.24 | 28.17 | 17.87 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 14.31 | 5.40 | 2.81 | 3.69 | 2.89 | - |
EV/EBITDA Ratio | 101.97 | 44.89 | 18.95 | 22.45 | 20.31 | - |
EV/EBIT Ratio | 266.31 | 143.92 | 41.17 | 34.24 | 28.57 | - |
EV/FCF Ratio | 282.89 | 46.20 | 25.82 | 180.58 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.00 | 0 | 0.00 | 0 | 0.00 | 0.05 |
Debt / EBITDA Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.13 |
Debt / FCF Ratio | 0.02 | 0.01 | 0.02 | 0.02 | - | 2.11 |
Net Debt / Equity Ratio | -0.54 | -0.55 | -0.49 | -0.46 | -0.50 | -0.12 |
Net Debt / EBITDA Ratio | -6.67 | -7.59 | -5.32 | -3.94 | -4.69 | -0.32 |
Net Debt / FCF Ratio | -18.34 | -7.81 | -7.24 | -31.73 | 6.94 | -5.02 |
Asset Turnover | 0.52 | 0.53 | 0.56 | 0.63 | 0.89 | 1.44 |
Inventory Turnover | 8.43 | 9.08 | 8.60 | 8.56 | 8.32 | 8.20 |
Quick Ratio | 6.56 | 5.69 | 5.34 | 5.07 | 4.28 | 1.29 |
Current Ratio | 7.27 | 6.27 | 5.87 | 5.70 | 4.88 | 1.86 |
Return on Equity (ROE) | 3.13% | 2.48% | 5.29% | 8.18% | 14.38% | 29.92% |
Return on Assets (ROA) | 1.75% | 1.23% | 2.37% | 4.25% | 5.63% | 13.76% |
Return on Invested Capital (ROIC) | 5.90% | 3.90% | 7.09% | 12.83% | 18.04% | 33.18% |
Return on Capital Employed (ROCE) | 3.10% | 2.20% | 4.20% | 7.60% | 7.50% | 28.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.35% | 0.65% | 2.34% | 2.62% | 3.56% | - |
FCF Yield | 0.33% | 1.85% | 3.03% | 0.47% | -2.64% | - |
Dividend Yield | 0.19% | 0.47% | 1.21% | 1.22% | 1.80% | - |
Payout Ratio | 62.86% | 107.82% | 68.00% | 56.42% | 0.88% | - |
Buyback Yield / Dilution | -0.00% | -0.01% | -0.00% | -14.28% | -16.66% | 0.24% |
Total Shareholder Return | 0.19% | 0.46% | 1.21% | -13.05% | -14.87% | 0.24% |